Andreas Kjær

Andreas Kjær

Professor


  1. 2023
  2. Published

    International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology

    Veit-Haibach, P., Ahlström, H., Boellaard, R., Delgado Bolton, R. C., Hesse, S., Hope, T., Huellner, M. W., Iagaru, A., Johnson, G. B., Kjær, Andreas, Law, Ian, Metser, U., Quick, H. H., Sattler, B., Umutlu, L., Zaharchuk, G. & Herrmann, K., 2023, In: European Journal of Nuclear Medicine and Molecular Imaging. 50, 12, p. 3513-3537

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trials

    Wretlind, A., Curovic, V. R., de Zawadzki, A., Suvitaival, T., Xu, J., Zobel, E. H., von Scholten, B. J., Ripa, Rasmus Sejersten, Kjær, Andreas, Hansen, T. W., Vilsbøll, Tina, Vestergaard, H., Rossing, Peter & Legido-Quigley, C., 2023, In: Lipids in Health and Disease. 22, 1, 12 p., 160.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Treatment of inoperable large cell neuroendocrine lung cancer with single agent temozolomide

    Ørting, A. M., Clausen, M. M., Soldath, Patrick, Petersen, René Horsleben, Knigge, Ulrich, Andreassen, Mikkel, Kjær, Andreas & Langer, Seppo W., 2023, In: Acta Oncologica. 62, 12, p. 1952-1955 4 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

Previous 1 2 3 4 5 Next

ID: 13402